![]() ![]() Clinicians should consider local seasonal influenza activity when deciding whether to test patients for influenza. Children with influenza documented by testing may be treated with an influenza antiviral, with more rapid resolution of symptoms possible, allowing for earlier return to school, per AAP policy. Diagnosis of some other infections that share symptoms with SARS-CoV-2 (eg, influenza) may be clinically actionable, and coinfections may occur. Decisions regarding testing for other pathogens should be informed by local epidemiology, including current levels of community transmission. ![]() Testing for SARS-CoV-2 infection should be guided by clinician judgment in accordance with the prevalence of COVID-19 in a given community. Does the community prevalence of COVID-19 or other respiratory infections influence testing decisions? See AAP Newborn Guidance for additional information about testing newborn infants. Patients who are required to obtain screening tests based on local public health authorities, school districts, or other local organizations should be tested as required.Patients who are asymptomatic but have had close contact with an individual who has confirmed or probable COVID-19 should be tested at least 5 days after last exposure however, these patients should be tested immediately if they develop symptoms consistent with COVID-19.Patients who have symptoms consistent with COVID-19 should be tested immediately.The 3 common reasons and optimal timing for COVD-19 testing are as follows: Testing Indications When should patients be tested for COVID-19? Links to guidelines and research from the Centers for Disease Control and Prevention (CDC) and other organizations are provided for additional information to help guide decision making. In addition, the spectrum of clinical disease and epidemiology of transmission may differ between SARS-CoV-2 variants in circulation in specific geographic regions. No guidance can cover all clinical scenarios, and information regarding SARS-CoV-2/COVID-19 is evolving rapidly. The document also provides algorithms for common testing scenarios and information about practical considerations for in-office testing for SARS-CoV-2. This guidance is intended to assist pediatricians in understanding indications for SARS-CoV-2 testing as well as test selection and interpretation. In addition, population-level testing helps determine what interventions may need to be put in place to control the spread of disease within a community. Testing for infection with SARS-CoV-2, the virus that causes COVID-19, can inform individual patient care and decision making for parents and families. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |